Business profile & competitive position
AMETEK, Inc. operates in the Industrials sector, specifically the Electrical Equipment & Parts industry. The company describes itself as a global manufacturer of electronic instruments and electromechanical devices, organized into two operating groups: Electronic Instruments (EIG) and Electromechanical (EMG). EIG produces advanced analytical, test and measurement instruments for process, aerospace, power and industrial end markets, while EMG supplies precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects to aerospace and defense, medical, automation and broader industrial markets.
The margin and return profile reinforces the case that AMETEK sits toward the higher-quality end of the electrical-equipment peer set. Its net margin is 19.9% and return on equity is 14.7%. A near-20% net margin is well above what a typical diversified industrial generates, suggesting pricing power, recurring aftermarket exposure and disciplined cost management rather than pure commodity component manufacturing. The 14.7% ROE, while not extraordinary, is solid for a capital-intensive hardware business and indicates that operating assets are producing meaningful profitability for shareholders. Those figures are consistent with a business model tilted toward specialized, often specification-critical components and instruments rather than highly cyclical, low-margin commoditized electrical products.
Financial posture
As of the current snapshot, AMETEK carries a market capitalization of $52.4 billion and trades at a P/E ratio of 32.1. That multiple is elevated relative to the broader industrials complex and signals that the market is already pricing in above-average earnings growth and a durable franchise. The 19.9% net margin and 14.7% ROE provide some fundamental justification for the premium, because consistent profitability and capital returns are exactly what allow a manufacturer to compound value over time. However, a P/E above 30 also leaves less room for execution stumbles and means the stock’s path will be sensitive to whether growth can remain above the industrial average.
The stock’s beta is 0.97, essentially market-neutral, implying AMETEK does not typically magnify broad market swings by a meaningful degree. That fits a company with a diversified customer base and a significant non-U.S. revenue footprint. At the current price of $228.67, the shares sit below the 50-day exponential moving average of $243.02, with an RSI of 38.5. That is a near-term technical picture of soft momentum without yet reaching the traditional oversold threshold near 30.
Strategic priorities & outlook
AMETEK’s most recent 10-K frames the company’s roadmap around four operational pillars. First, management is executing the “AMETEK Growth Model,” which targets high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. In 2025, the company translated that model into reported sales of $7,401.1 million, up 6.6% from 2024, and diluted EPS of $6.40, up 7.9%. It also cited record operating income, net income, orders and backlog, implying that execution has recently trended in line with the model’s ambitions.
Second, operational excellence remains a formal priority, with emphasis on lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, digitalization and artificial intelligence. Third, acquisitions are central to the narrative. From 2021 through December 31, 2025, AMETEK completed 15 acquisitions representing roughly $1.8 billion in annualized sales. In 2025 alone, the company deployed $933.2 million in cash, net of cash acquired, to buy Kern (high-precision machining and optical inspection solutions) and FARO Technologies (3D measurement and imaging solutions). These deals fit the stated strategy of adding technically complementary assets aligned with secular growth themes. Fourth, global expansion is pursued partly through best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia, aimed at customer proximity and international growth.
Macro & geopolitical exposure
As an Industrials / Electrical Equipment & Parts company, AMETEK is exposed to the capital-expenditure and replacement cycles of manufacturing, aerospace, power, medical and automation customers. Demand for its instruments and electromechanical components rises when industrial customers invest in capacity, precision measurement and process automation, and contracts when capex budgets are cut. The aerospace and defense exposure implies sensitivity to defense spending trajectories and commercial aerospace build rates, while the medical components business introduces exposure to healthcare capital budgets and medical-device regulation.
The sector classification also implies meaningful cross-border exposure. In 2025, AMETEK derived 52% of EIG net sales and 42% of EMG net sales from customers outside the United States. That profile brings in currency translation effects as well as trade-policy risks such as tariffs, export controls and customs friction. The company’s manufacturing footprint in China, Czechia, Malaysia, Mexico and Serbia is relevant here: it provides regional sourcing and selling flexibility, but facilities in multiple jurisdictions also create exposure to local labor, environmental and data-transfer regulations. Commodity inputs, including specialty metals and electronic components, can pressure margins during periods of tight supply or volatile pricing.
Recent developments
The most recent news cluster centers on the November 3, 2026 quarterly report and its aftermath. On November 4, 2026, Zacks reported that AMETEK’s Q3 earnings beat estimates on organic sales and margin gains. That same day, 247wallst.com placed AMETEK alongside Eaton and Dover in a discussion of record results and the sustainability of dividend growth. On November 3, 2026, MarketBeat published Q3 earnings call highlights. Two days later, on November 6, 2026, AMETEK declared its quarterly dividend, according to PR Newswire.
Separately, the 2025 operating record and the two sizable acquisitions (Kern and FARO) suggest management is actively redeploying cash into growth rather than allowing the balance sheet to idle. The recurring quarterly dividend declaration also keeps AMETEK in the income-growth conversation, a theme picked up by the recent dividend commentary in the financial press.
Earnings behavior & post-earnings drift
AMETEK has a consistent record of exceeding the official EPS consensus. Over the last eight reported quarters, the company has beaten estimates in all eight, for a 100% beat rate, with an average earnings surprise of 4.3%. Despite the steady beats, the post-earnings price reaction has generally been modest. The average 5-day move after earnings across those quarters is 0.8%, classified as an upward drift.
The four most recent quarters show the nuance behind that headline. On November 3, 2026, AMETEK reported EPS of $2.21 versus a $2.11 estimate, a 4.7% beat, yet the stock fell 4.62% the next day and was flat over the following five days. On August 4, 2026, EPS of $2.09 beat the $1.99 estimate by 5.0%, and the stock rose 0.28% the next day and 0.89% over the next five sessions. The April 30, 2026 report was a $1.97 print against a $1.90 estimate, a 3.7% beat, but the shares dropped 2.13% the following day and slipped 0.33% over five days. The February 3, 2026 quarter delivered $2.01 versus $1.94, a 3.6% beat, with a next-day decline of 0.48% but a five-day gain of 1.83%.
The takeaway is that AMETEK usually clears the consensus bar, but beat magnitude and the subsequent price reaction are not tightly correlated. The market’s real expectation may already embed a small beat, which helps explain why even a 4.7% or 5.0% positive surprise sometimes produces a flat or negative immediate response. The next scheduled report is February 2, 2027 before the market open, with a consensus EPS estimate of $2.28.
For a deeper dive, readers should review the full institutional verdict, which aggregates sell-side models, price targets and peer comparisons beyond the headline numbers covered here.
Frequently Asked Questions
What does AMETEK actually manufacture?
AMETEK manufactures electronic instruments and electromechanical devices through two groups: Electronic Instruments (EIG), which makes analytical, test and measurement instruments, and Electromechanical (EMG), which supplies precision motion control, medical components, thermal management systems, specialty metals and electrical interconnects.
How reliable has AMETEK been at beating earnings estimates?
Over the last eight reported quarters, AMETEK has beaten the consensus EPS estimate every time, with an average surprise of 4.3%. The most recent quarter, reported November 3, 2026, delivered $2.21 versus a $2.11 estimate, a 4.7% beat.
What is AMETEK’s growth strategy?
The company’s 10-K outlines the AMETEK Growth Model, targeting high-single-digit annual sales growth and double-digit annual EPS growth, supported by operational excellence programs, strategic acquisitions and global expansion through facilities in China, Czechia, Malaysia, Mexico and Serbia.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-11-03 | $2.21 | $2.11 | +4.7% | -4.62% | null% |
| 2026-08-04 | $2.09 | $1.99 | +5% | +0.28% | +0.89% |
| 2026-04-30 | $1.97 | $1.9 | +3.7% | -2.13% | -0.33% |
| 2026-02-03 | $2.01 | $1.94 | +3.6% | -0.48% | +1.83% |
| 2025-10-30 | $1.89 | $1.76 | +7.4% | - | - |
| 2025-07-31 | $1.78 | $1.69 | +5.3% | - | - |
Previous AME editions
Get the institutional verdict on AME
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the AME verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.